Source BioScience UK Ltd, an industry-leading provider of genomic services and histopathology diagnostics, today announced it had completed the acquisition of Cambridge Clinical Laboratories (CCL ...

Lexaria Bioscience (LEXX) announced that dosing has begun as scheduled in its human study GLP-1-H25-5 that is comparing oral DehydraTECH-liraglutide to injected Saxenda-branded liraglutide.

09:39 EDT Regencell Bioscience (RGC) Holdings Ltd trading resumes Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Published ...

Niagen Bioscience’s state-of-the-art research and development facility in Longmont, CO, which serves as the hub for the Company’s gold-standard quality practices The rebrand celebrates the ...

On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures that have been extinct for more than 12,000 years ...

In this article, we are going to take a look at where Regencell Bioscience Holdings Limited (NASDAQ:RGC) stands against other stocks that posted double-, triple-digit gains last week. Micro- and ...

Or it was – until now. The US company Colossal Biosciences claims to have revived the animal. The company from Austin in the US state of Texas calls itself “the world's only de-extinction ...

INTEGRA Biosciences has played a pivotal role in advancing the field of serological pipetting over the last 40 years, and has just created a fascinating article covering the fast-paced history of ...

HC Bioscience is shutting down after conducting preclinical models for a transfer RNA (tRNA) asset designed to treat hemophilia A. The Cambridge, Massachusetts-based biotech is closing ...

A species of wolf that died out some 12,500 years ago lives again as the “world’s first successfully de-extincted animal,” according to Dallas-based biotech company Colossal Biosciences.

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its strategic reboot. The company will henceforth be known as Whitehawk ...

Shares of Precision BioSciences, Inc. DTIL rose sharply in today's pre-market trading. Precision BioSciences reported clearance of investigational new drug application by the U.S. FDA for first-in ...